Abstract
The present review was designed to integrate both experimental and clinical data and to focus on the problems of management of severe cases of acute organophosphate poisoning, which always show CNS involvement. AChE activity, in discrete regions of the human brain, was studied by quantitative histochemistry of 40 μ thick sections. The regional effects of AchE inhibition by organophosphates was examined in a comparative study of the brains of two victims and two control brains, matched for age and sex. The pattern of AChE inhibition was regionally selective. The most significant decreases were observed in the neocerebellum, thalamic nuclei and the cortex. This specific distribution of AChE inhibition may be correlated with some of the clinical characteristics of acute organophosphate poisoning. The diagnostic value of blood AChE levels was examined in a personal series of 53 patients, who needed artificial ventilation, intensive care monitoring and antidotal treatment. The effects and side-effects of the antidotal treatment were reassessed. Recommended regimen of therapy was outlined, based upon experience in this series and in recent animal studies. The logical therapy would be and almost always in the co-administration of an anticholinergic drug (usually atropine) and an AChE reactivator (oximes) in order to rapidly obtain the most beneficial effect in the critically ill patient. Seizures that do not respond to the specific antidotal therapy, should be treated with I.V. benzodiazepines. Artificial respiration and supportive measures are essential for patient' survival. They enable the patient to gain the necessary time for sufficient recovery of AChE activity.
Sommario
Questa relazione si propone di correlare i dati clinici e sperimentali e i problemi di comportamento nei casi di avvelenamento acuto da organofosfati nei quali vi è sempre coinvolgimento del sistema nervoso centrale. L'attività dell'acetilcolinesterasi (AChE) è stata studiata in diverse regioni cerebrali con metodiche di istochimica quantitativa. Gli effetti regionali della inibizione della AChE da parte degli organofosfati sono stati comparati sui cervelli di 2 vittime e di 2 controlli paragonabili per sesso e per età e si è visto che il danno è regionalmente selettivo. Il maggior difetto è stato constatato nel neocervelletto, nei nuclei talamici e nella corteccia. Questa distribuzione così specifica nella inibizione di AChE può essere correlata con alcune caratteristiche cliniche dell'avvelenamento da organofosfati. Il dato diagnostico dei livelli ematici di AChE è stato esaminato in una serie di 53 pazienti che hanno avuto necessità di ventilazione artificiale, di cure intensive e di trattamento con antidoti. Gli effetti e i controeffetti del trattamento sono stati riconsiderati ed è stato elaborato e raccomandato uno schema di terapia ricavato da questa esperienza e da recenti ricerche eseguite su animali. La terapia più logica vuole sempre l'associazione di un farmaco anticolinergico (solitamente l'atropina) e di reattivatori dell'AChE, gli ozimi, per poter ottenere rapidamente effetti benefici. Le crisi convulsive, poi, che non rispondono al trattamento di base, devono essere sedate colle benzodiazepine. La respirazione artificiale è essenziale per la sopravvivenza del malato e va unita ad altre terapie di supporto capaci di guadagnare il tempo necessario per la ripresa dell'attività della AChE.
References
Barnes J.M.:Anticholinesterases: Some problems in understanding their effect in whole animals. In Ballantyne B (ed): Foresnic Toxicology, Wright, pp. 79–85, 1974.
Bartus R.T., Dean R.L., Beer B., Lippa A.S.:The cholinergic hypothesis of geriatric memory dysfunction. Science 217: 408–417, 1983.
Bertram U., Kasten A., Lullmann H., Ziegler A.:Improved treatment of OP intoxication by use of scopolamine or dexetimide. Experientia (Basel), 33: 1196–1197, 1977.
Biegon A., Wolff M.:Quantitative histochemistry of acetylcholinesterase in rat and human brain postmortem. J. Neurosci. Meth. 16: 39–45, 1985.
Bowers M.B., Goodman E., Sim V.M.:Some behavioral changes in man following acetylcholinesterase administration. J. Nerv. Ment. D. 138:383–391, 1964.
Crane C.R., Sanders D.C., Abbott J.K.:Use and interpretation of AChE measurements. In Sunshine I (ed). Methodology for Analytical Toxicology. West Palm Beach, Florida, CRC Press, pp. 86–87, 1975.
Ce Candole C.A., Douglas W.W., Lovatt-Evans C., Holmes R., et al:The failure of respiration in death by anticholinesterase poisoning. Brit. J. Pharmacol. 8:466–475, 1954.
Drachman D.A., Leavitt J.:Human memory and the cholinergic system. A relationship to aging? Arch Neurol. 30:113–121, 1974.
Durham W.F., Hayes W.J.:Organo phosphorous poisoning and its therapy, with special reference to modes of action and compounds that reactivate inhibited cholinesterase. Arch. Environ. Health 5:21–28, 1962.
Echobichon E.J.:OP ester insecticides. In Echobichon E.J. Joy RM (eds): Pesticides and Neurological Diseases. Boca Raton, CRC Press, pp. 151–204, 1982.
Echobichon E.J., Ozere R.L., Reid E., Crocker J.F.S.:Acute phenitrothon poisoning. Can. Med. Assoc. J. 116, 377–379, 1977.
Erdmann W.D.:Antidotal therapy in OP poisoning. Arch. Toxikol 24:30–40, 1968.
Finkelstein Y., Kushnir A., Taitelmann U.:Antidotal treatment for CNS manifestations of acute OP poisoning: effects and side effects. Isr. Neurol. Assoc., Annual Meeting, Abst. p. 24, 1987.
Finkelstein Y., Wolff M., Biegon A.:Differential inhibition of AChE activity in discrete regions of the human brain after parathion intoxication: a quantitative histochemical study. Int. Neurotoxicol. Assoc. Meeting Abst. 1:82, 1987.
Finkelstein Y., Wolff M., Biegon A.:Brain AChE after parathion poisoning: a comparative quantitative histochemical analysis postmortem. Toxicol., in press, 1988.
Firemark H., Barlow C.F., Roth L.J.:The penetration of 2-PAM-C 14 into brain and the effect of ChE inhibitors on its transport. J. Pharmacol. Exp. Ther. 145:252–265, 1964.
Francis P.T., Palmer A.M., Sims N.R.:Neurochemical studies of early-onset Alzheimer's disease. N. Eng. J. Med. 313:7–11, 1985.
Goldfrank L.R., Bresnitz E.A., Kirstein R.H., Howland M.A.:Organophosphates. In Goldfrank L.R., Flamenbaum N.E., Lewin N.A., Weismann R.S., Howland M.A., Kulberg A.G.: Toxicologic Emergencies. Norwalk, Conn., Appleton-Century-Grofts, 3rd ed., pp. 686–696, 1986.
Gray A.P.:Design and structure-activity relationships of antidotes to OP anti-ChE agents Drug. Metab. Rev. 15:557–589, 1984.
Green D.M., Muir A.W., Stratton J.A., Inch T.D.:Dual mechanism of the antidotal action of atropine-like drugs in poisoning by OP anti-ChE. J. Pharm. Pharmacol. 29:62–64, 1977.
Grob D.:Anticholinesterase introxication in man and its treatment. In Koëlle G.B. (ed.): ChE anti-ChE agents. Handbuch der Experimentellen Pharmakologie, vol. 15. Berlin: Springer, pp. 1003–1032, 1963.
Grob D., Harvey A.M.:The effects and treatment of nerve gas poisoning. Am. J. Med. 14:52–60, 1953.
Haddad L.M.:The OP insecticides. In Haddad L.M. Winchester J.F. (eds): Clinical Management of Poisoning and Drug Overdose. Philadelphia, W.B. Saunders, pp. 704–710, 1983.
Hayes W.J.:Pesticides in relation to publich health. Ann. Rev. Entom. 5:379–384, 1959.
Hayes W.J.:Diagnosis and treatment of poisoning. In Hayes W.U. (ed): Toxicology of Pesticides. Baltimore, Williams and Wilkins, pp. 409–417, 1975.
Hazard R., Cheymol J., Levy J., Boissier J.-R., Lechat P.:Manuel de pharmacologie. Paris, Masson, pp. 180–181, 1963 (in French).
Heiss W.-D.:Regional cerebral blood flow measurement using a scintillate scintillation camera. Clin. Nuc. Med. 4:385–396, 1979.
Henry J.B.:Todd-Stanford-Davidsohn Clinical Diagnosis by Laboratory Methods. Philadelphia. Saunders W.B., 16th ed, 1979.
Holmes R.:The mechanism of respiratory failure in the rabbit poisoned with GB. Proton Technical Papers 275, 1952.
Holmes R.:The effects of GB on the respiration of the monkeys. Proton Technical Papers 316, 1954.
Holmstedt B., Krook L., Rooney D.R.:The pathology of experimental cholinesterase-inhibitor poisoning. Acta Pharmacol. (Koh.) 13:337–344, 1957.
Isseroff A., Lancet D.:An inexpensive microcomputer-based image-analysis system: novel applications to quantitative autoradiography: J. Neurosci. Meth. 12:265–275, 1985.
Janowsky D.A., El-Yousef M.K., Davis J.M.:A cholinergic adrenergic hypothesis of mania and depression. Lancet 2:632–635, 1972.
Jovic R., Milosevic M.:Effective doses of some cholinolytics in the treatment of anti-AChE poisoning. Eur. J. Pharmacol. 12:85–93, 1970.
Kalow W., Genest K.:A method for the detection of atypical forms of human serum cholinesterase Determination of dibucaine numbers. Can. J. Biochem. Physiol. 35:339–348, 1957.
Karczamar A.G.:Pharmacologic, toxicologic and therapeutic properties of anticholinesterease agents. In Root W.S., Hofmann F.J. (eds). Physiological Pharmacology, vol. III part C. Autonomic Nervous System Drugs. New York, N.Y.: Academic Press, 163–322, 1967.
Khaitov R.K., Baymuradov T.B., Kaydrov U.S.:Therapeutic efficiency for atropine and dipyroxime. Veterinarya (Moscow) 11:86–87, 1972 (in Russian).
Köelle G.B.:Neurochemical transmission and the autonomic nervous system. In Goodman L.S., Gilman A. (eds): The Pharmacological Basis of Therapeutics. New York, N.Y.: MacMillan, 404–445, 1975.
Köelle G.B.:Cytological distribution and physiological functions of ChE's. In Köelle G.B. (ed): Handuch der Experimentellen Pharmakologie: ChE's and Anti-ChE agents. Berlin: Springer-Verlag, Supp. 15:187–298, 1963.
Koeller W.C., Klawans H.L.:Organophosphorus introxication. In Vinken P.J., Bruyn G.W. (eds): Handbook of Clinical Neurology, vol. 37, Amsterdam: Elsevier/North Holland Biomedical Press, 541–562, 1979.
Levin H.S., Rodnitzky R.L.:Behavioral effects of organophosphate pesticides in man. Clin. Toxicol. 9:391–405, 1976.
Long K.R.:ChE activity as a biological indicator of exposure to pesticide. Int. Arch. Occup. Environ. Health 36:75–87, 1976.
Lotti M., Becker C.E.:Treatment of acute OP poisoning: evidence of a direct effect on central nervous system by PAM-2. J. Toxicol. Clin. Toxicol. 19:121–127, 1982.
Luria A.R., Karasseva T.A.:Disturbances of auditory speech memory in focal lesions of the deep regions of the left temporal lobe. Neuropsychologia 6:97–104, 1968.
Luria A.R.:Brain disorders and language analysis. Language and Speech 1:14–34, 1958.
Luria A.R.:The functional organization of the brain. Scient. Amer. 222:66–78, 1970.
Luria A.R., Homskaya E.D.:Frontal lobes and the regulation of activation processes. In Mostofsky D. (ed). Attention: Contemporary Theory and Analysis. New York: Appleton Century, Crofts, 1970.
Maresh W.:Die Vergiftung durch phosphosäure-ester. Arch. Toxicol. 16:285–319, 1957.
Massoulie J., Bon S.:The molecular forms of ChE and AChE in vertebrates. Ann. Rev. Neurosci. 5:57–106, 1982.
Meflah K., Bernard S., Massoulie J.:Interactions with lectins indicate differences in the carbohydrate composition of the membrane-bound enzymes acetylcholinesterase and 5′-nucleotidase in different cell types. Biochimie 66:59–69, 1984.
Mesulam M.M.:Attention, confusional states and neglect. In Mesulam M.M. (ed): Principles of Behavioral Neurology. Philadelphia: Davis, 125–168, 1985.
Mesulam M.M., Volicer L., Marquis J.K., Mufson E.J., Green R.C.:Systematic regional differences in the cholinergic innervation of the primate cerebral cortex: Distribution of enzyme activities and some behavioral implications. Ann. Neurol. 19:144–151, 1986.
Metcalf D.R., Holmes H.H.:Psychological and neurological alterations in humans with organophosphorous exposure. Ann. N.Y. Acad. Sci. 160:357–361, 1969.
Muller F., Dumez Y., Massouli J.:Molecular forms and solubility of AChE during the embryonic development of rat and human brain. Brain Res. 331:295–302, 1984.
Morgan D.P.:Recognition and management of pesticide poisoning. Washington D.C. U.S. Environmental Protection Agency. 3rd ed., 1982.
Namba T., Kiraki K.:PAM therapy for alkylphosphate poisoning. JAMA 166:1834–1839, 1958.
Namba T., Nolte C.T., Jackrel J., Grob D.:Poisoning due to organophosphate insecticides: Acute and chronic manifestations. Am. J. Med. 50:475–492, 1971.
Pelfrene A.F.:Acute poisoning by carbamate insecticides and oxygen therapy. J. Toxicol. Clin. Exp. 6:313–318, 1986.
Reynolds J.E.F., Prasad A.B.:Martindale, The Extra Pharmacoloeia, 28th ed, London, pp. 389–390, 1505, 1982.
Schoene J., Oldiges H.:Antidotal action of pyridinium salts for tabun and sarin poisoning in vivo and in vitro. Arch. Int. Pharmacodyn. Ther. 204:110–123, 1973 (in German).
Disell F.R.:The reactivability of ChE inhibited by Vx and Sarin in man, Toxicol. Appl. Pharmacol. 27:241–246, 1974.
Smith P.W.:Bulletin: Medical Problems in Aerial Applications. Office of Aviation Medicine, Federal Aviation Administration, Dept. of Transportation. Washington D.C., p. 5, April 1977.
Sterri S.H., Rognerud B., Fiskum S.E., Lyngaas S.:Effect of toxogonin and P2S on the toxicity of carbamates and OP compounds. Acta Pharmacol. et Toxicol. 45:9–15, 1979.
Stewart W.C.:The effect of sarin and atropine on the respiratory center and neuromuscular junction of the rat. Conn. J. Biochem. physiol. 37:362–367, 1959.
Stewart W.C., Anderson E.A.:Effect of ChE inhibitors when injected into the medulla of the rabbit. J. Pharmacol Ex. Ther. 162:309–316, 1968.
Taitelman U., Adler M., Levy I., Dikstein S.:Treatment of massive poisoning by the OP pesticide methidathion. Clin. Toxicol. 8:277–282, 1975.
Taylor P.:Anticholinesterase agents. In Goodman L.S., Gilman A. (eds). The Pharmacological Basis of Therapeutics. 6th ed., New York: MacMillan Publishing Co., pp. 100–119, 1980.
Traub K., Olson K., Pindzola M., Spences L.:Quantitative autoradiography of 14 C-Soman distribution in the rat brain. Abstract. J. Neurol. 232 (suppl.):552, 1985.
Vale J.A., Scott G.W.:OP poisoning. Guy's Hosp. Rep. 123 13–25, 1974.
Vasic B.V., Milosevic M.P., Terzic M.R.:ACh content and ChE activity in the ponto-medullary region of brain in rats treated with armin and obidoxime. Biochem. Pharmacol. 26:601–602, 1977.
Weinstock M., Kay G., Razin, M., Enz A.:Selective acetylcholinesterase inhibition and acetylcholine elevation in different brain areas of the rat. Abstracts of the Int. Symp. on muscarinic cholinergic mechanisms, Tel Aviv 41, 1986.
World Health Organization:Environmental Health Criteria 63, Organophosphorous Insecticides: A General Introduction. Geneva, W.H.O., 1986.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Finkelstein, Y., Taitelman, U. & Biegon, A. CNS involvement in acute organophosphate poisoning: Specific pattern of toxicity, clinical correlates and antidotal treatment. Ital J Neuro Sci 9, 437–446 (1988). https://doi.org/10.1007/BF02337161
Issue Date:
DOI: https://doi.org/10.1007/BF02337161